csu
Xolair gets FDA approval for skin condition
March 24, 2014Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu
An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
